Integra, set up by Yissum to invest in life science spinouts from Hebrew University of Jerusalem, has secured an initial tranche led by Temasek.

Evotec has injected $17.7m into Exscientia, becoming the first strategic shareholder in the drug discovery spinout based on research at University of Dundee.

The pharmaceutical company has invested in healthcare analytics software provider Caresyntax through its corporate venturing subsidiary.

The spinout has turned to Stanford-Start X Fund as it prepares to add data sciences, engineering and clinical features to its machine-learning based service for health insurers.

Existing investor Merck & Co took part in a round that boosted the healthcare work management platform's overall funding to $135m.

Fusion Pharmaceuticals has closed its series A round at $46m following a $21m extension that featured medical device maker Varian Medical Systems.

The list includes spinouts aiming to tackle arthritis, cognitive disabilities and diseases of citrus plants.

The cancer treatment developer spun out from UCL has secured $80m in series C capital from investors including Woodford Investment Management and Syncona.